FDA completed mid-cycle review of INO-3107, and Inovio Pharmaceuticals announced the appointment of EY as its independent registered public accounting firm.

The entities involved

• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• Inovio Pharmaceuticals →

  American biotechnology company

  • Inovio Pharmaceuticals and Synlogic, Inc. are identified as competing small-cap healthcare companies.Sat 10:40
• Ernst & Young LLP →

  Nothing else this week.

• Securities and Exchange Commission →

  government agency of the Philippines

  • BlackRock, the manager of the iShares Core MSCI EAFE ETF, has made required filings with the Securities and Exchange Commission regarding institutional holdings.Mon 16:42
  • Filing required regarding institutional holdings for Schwab Emerging Markets Equity ETF and Waterford Advisors LLC with the SEC.Mon 16:38

Related events

• Decoy Therapeutics is listed on the Nasdaq stock exchange and is currently seeking expedited regulatory approval via FDA pathways.Sep 22
• Mylan is seeking regulatory approval from the FDA for new products and has listed its stock on the Nasdaq exchange.Sep 2
• The FDA placed a clinical hold on the IND application for the company Aardvark.Jul 30
• Elutia is trading on the Nasdaq stock exchange and requires regulatory clearance from the FDA for product launches.Aug 15
• FDA approval enables commercial opportunity involving CBRE Group.Sep 17